Volume 7

An ephemeris of materia medica, pharmacy, therapeutics and collateral information / by Edward F. Squibb.

  • Squibb, Edward Robinson, 1819-1900.
Date:
1885-
Catalogue details

Licence: Public Domain Mark

Credit: An ephemeris of materia medica, pharmacy, therapeutics and collateral information / by Edward F. Squibb. Source: Wellcome Collection.

    11/144 (page 9)
    Dr. F. Mendel of Essen, Prussia relates his experience in over 400 cases of intravenous injection of Sodium Cacodylate, and concludes that it is a perfectly safe and very efficient means of obtaining the full therapeutic effects of arsenic. In cases of anemia and chlorosis in which the treatment was kept up from four to six weeks, he obtained results which he had not before observed with iron in any of its forms. (Therap. Monats., Yol. XYI, p. 178). He has also met with success in the use of the following by the mouth: Sodium Cac-odylate. 2 grammes ( 30.9 grains) Oil of Peppermint. 2 drops Simple Syrup. 24 grammes (370.4 “ ) Water sufficient to make 175 Cc. (about 6 fluidounces) The dose is 5 grammes (a teaspoonful) three times a day. Dr. Paul Gallois of Paris, France reported at a meeting of the Paris Therapeutical Society on October 9th last his experience in the use of the Cacodylic medication in chronic bronchitis accom¬ panied with severe asthma. He obtained very marked results by using the following formula : Sodium Cacodylate.. . .. 2 grammes (about 30 grains) Rum. .20 cc ( “ 5 drachms) Simple Syrup. .20 cc ( “ 5 “ ) Distilled Water. .60 cc (2 fluidounces) Essence of Peppermint. . 1 or 2 drops This was given in 5 gramme (1 teaspoonful) doses after each meal for ten days followed by an interruption of ten days. He found it of value in other affections as well. {Bull. Gen. de Therap., second half of 1901, p. 878). Dr. Burlureaux of Paris, France has had Cacodylic medication under careful observation for a year or so past and now reports at a meeting of the French Society of Dermatology and Syphilo- graphy on March 6th last that it cannot be compared with the usual forms of arsenic medication, and looks forward to continued success in the future, particularly with intramuscular injections of Quinine Cacodylate. (Annal. de Berm, et de SyphylYol. Ill, p. 255). At variance with the report of some other observers in the use of this agent in cases of inoperable carcinoma Dr. Lucien Le Roy of